Company intelligence / Profile preview

Hubei Ipure Biotech

Wuhan, Hubei, China

Ownership: Private
Development stage: Other

Overview

Hubei Ipure Biotech is a manufacturer and supplier of pharmaceutical raw materials (APIs), pharma intermediates, and related fine chemicals, operating at commercial scale with GMP production facilities. There are no publicly reported clinical trials or clinical stage new drug programs.

Modalities: Small molecule
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on Hubei Ipure Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hubei Ipure Biotech.

Explore the full profile